Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griguolo

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Critical Reviews in Oncology/Hematology|August 16, 2024
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectivesAlessandra Ferro, Michele Bottosso, Maria Vittoria Dieci, et al.
International Journal of Molecular Sciences|November 4, 2020
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic StrategiesGiovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, et al.
Critical Reviews in Oncology/Hematology|October 20, 2023
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical dataGuido Giordano, Gaia Griguolo, Matteo Landriscina, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomesGaia Griguolo, Michele Bottosso, Andrea Crema, et al.
International Journal of Cancer|June 6, 2022
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohortIvica Ratosa, Nika Dobnikar, Michele Bottosso, et al.
Breast (Edinburgh, Scotland)|May 21, 2026
Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 yearsGiorgio Bonomi, Davide Napetti, Gaia Griguolo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2020
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
British Journal of Cancer|January 30, 2023
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastasesMichele Bottosso, Gaia Griguolo, Léa Sinoquet, et al.
International Journal of Cancer|May 27, 2023
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patientsGaia Griguolo, Vittoria Aldegheri, Michele Bottosso, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|August 16, 2024
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectivesAlessandra Ferro, Michele Bottosso, Maria Vittoria Dieci, et al.
International Journal of Molecular Sciences|November 4, 2020
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic StrategiesGiovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, et al.
Critical Reviews in Oncology/Hematology|October 20, 2023
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical dataGuido Giordano, Gaia Griguolo, Matteo Landriscina, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomesGaia Griguolo, Michele Bottosso, Andrea Crema, et al.
International Journal of Cancer|June 6, 2022
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohortIvica Ratosa, Nika Dobnikar, Michele Bottosso, et al.
Breast (Edinburgh, Scotland)|May 21, 2026
Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 yearsGiorgio Bonomi, Davide Napetti, Gaia Griguolo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2020
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
British Journal of Cancer|January 30, 2023
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastasesMichele Bottosso, Gaia Griguolo, Léa Sinoquet, et al.
International Journal of Cancer|May 27, 2023
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patientsGaia Griguolo, Vittoria Aldegheri, Michele Bottosso, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Pageof 14